Radiotherapy for non-small cell lung cancer: evolution and development

XU Xinyan; CHEN Jiayan; MAO Jingfang; FAN Min

doi:10.19401/j.cnki.1007-3639.2020.10.008

您当前的位置：

首页 >

文章列表页 >

Radiotherapy for non-small cell lung cancer: evolution and development

更新时间：2026-01-27

- Radiotherapy for non-small cell lung cancer: evolution and development
- China Oncology Vol. 30, Issue 10, Pages: 777-784(2020)
- 作者机构：
  
  1. 复旦大学附属肿瘤医院放疗科，复旦大学上海医学院肿瘤学系,上海,200032
  2. 上海市质子重离子医院放疗科,上海,201321
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2020.10.008
  CLC：
- Published Online：12 November 2020，
  
  Published：12 November 2020
- 稿件说明：
移动端阅览
许新颜, 陈佳艳, 茅静芳, 樊　旼 . 非小细胞肺癌的放射治疗：演进与提高[J]. 中国癌症杂志, 2020, 30(10): 777-784.

XU Xinyan, CHEN Jiayan, MAO Jingfang, et al. Radiotherapy for non-small cell lung cancer: evolution and development[J]. China Oncology, 2020, 30(10): 777-784.
许新颜, 陈佳艳, 茅静芳, 樊　旼 . 非小细胞肺癌的放射治疗：演进与提高[J]. 中国癌症杂志, 2020, 30(10): 777-784. DOI： 10.19401/j.cnki.1007-3639.2020.10.008.

XU Xinyan, CHEN Jiayan, MAO Jingfang, et al. Radiotherapy for non-small cell lung cancer: evolution and development[J]. China Oncology, 2020, 30(10): 777-784. DOI： 10.19401/j.cnki.1007-3639.2020.10.008.

摘要

肺癌是全球范围内占首位的肿瘤相关死亡病因，非小细胞肺癌（non-small cell lung cancer，NSCLC）约占整体肺癌病例数的85%。长久以来，放射治疗（简称放疗）一直是肺癌的重要治疗手段之一。多年来随着放疗技术的不断发展以及针对NSCLC的基础和临床研究的不断深入，放疗在肺癌治疗领域的应用也得以不断拓展，并显示出广阔的未来发展前景。

Abstract

Lung cancer is the leading cause of tumor-related death worldwide

and non-small cell lung cancer (NSCLC) accounts for about 85% of all cases of lung cancer. Radiotherapy has long been one of the fundamental therapeutic approaches for lung cancer. Over the years

with the ever-accelerated development of radiotherapy technology and the deepened basic and clinical research on NSCLC

the application of radiotherapy in lung cancer treatment has been dramatically expanded

with a promising landscape for future development.

关键词

Keywords

references

Views

4530

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Advances in molecular mechanism of lung cancer: from rational to practice

Recent advances and prospect in targeted therapy for lung cancer

Lung cancer screening strategy for non-high-risk population

The global prevalence and prevention progress of lung cancer

Small cell lung cancer transformation from T790M-mutant lung adenocarcinoma following osimertinib treatment

Related Author

JIN Yujuan

HU Liang

JI Hongbin

HONG Shaodong

ZHANG Li

ZHOU Yaodong

CHEN Zongwei

CHEN Haiquan

Related Institution

Chinese Academy of Sciences Center for Excellence in Molecular Cell Science

Department of Medical Oncology, Sun Yat-sen University Cancer Center

复旦大学附属肿瘤医院胸外科，复旦大学上海医学院肿瘤学系

基因工程重点实验室

复旦大学胸部肿瘤研究所

AI问答

⁰